8:30 am Welcome Coffee & Registration
The Move from In-house to Clinical Outsourcing
9:30 am Chair’s Opening Address
9:40 am The Current R&D Procurement Landscape and the Comeback of Supplier Relationship Management (SRM) in the R&D Program
Synopsis
• What are the current trends within R&D procurement and sourcing including increasing dependence upon data
• What is SRM’s place within Sourcing and Procurement
• What value can be added from a dedicated SRM team
• Approaches to improving both existing and new partnerships for long-term gain
10:25 am Vendor Management vs. Category Management – Orchard Therapeutics’ Journey to Support an Increasingly Complex and Global Business
Synopsis
• Cost vs. benefits of each approach
• Gauging current/future organizational maturity, complexity and business needs to develop your procurement roadmap
• Influencing total cost of ownership to engrain procurement as a trusted business partner
10:55 am Speed Networking & Morning Coffee
11:55 am Discussion: Vendor Oversight and Risk Management Approaches Across the Pharma Industry
Synopsis
• Large, mid-sized and small pharma contrast how many internal resources are dedicated to vendor oversight activities? In what function do these resources reside?
• How are sponsors interpreting the guidelines in different ways, to avoid negative inspection?
• Having transitioned from large pharma to small biotech Rinaldo Doorman from Cerevel shares the difference in vendor oversight approaches
12:30 pm A fit-for-purpose R&D third party technical assessment – GSK Vaccines’ simplification of R&D partner’s compliance evaluation.
Synopsis
• In a context of R&D Acceleration, how to streamline capability assessment in the due diligence process
• Using a decision tree with few questions, how to save time and resources by performing only assessments that matter.
• Aligning Procurement and Quality processes to define best time for vendor technical assessment
• Vendor (on-paper) assessment vs. Vendor (on-site) auditing (Pro’s & Con’s)
• The importance of cultural considerations when assessing R&D partners
1:00 pm Networking Lunch
2:00 pm Case Study on Supplier Spend Analytics for Clinical Trials
Synopsis
• Data sources and software application
• Supplier spend history for analytics and contract negotiation
• Supplier budget monitoring and metrics
• Supplier spend forecasting to predict future challenges
2:30 pm Case Study: Automating and Harmonizing RFP Processes for a Phase 3 Neurodegenerative Rare Disease Clinical Trial Using Clinical MaestroTM
Synopsis
• End the pitfalls of Excel-based budgeting and simulate clinical study budgets and operational scenarios in a few hours
• See how bid and cost driver standardization increases bidding transparency and drives down costs
• Leverage information provided in bid negotiations to help Sponsors better understand exactly what they are paying for: rates, effort and services
• Examine how the sourcing for a phase 3 study was completed in 101 fewer hours, or 84% faster than traditional sourcing tools, using Clinical Maestro
3:00 pm Your Voice. Participate in 1 of 3 discussions, the top 3 points from each table will be shared
Synopsis
A: Will collaboration for market insight on supplier cost help or hinder competition?
B: Onshore vs offshore:What delivers the biggest total cost savings?
C: What are you top 3 negotiation tactics for minimizing spend?
3:45 pm Afternoon Tea & Networking Break
4:45 pm Contracting – Who Drives the Content
Synopsis
• Dissecting the best governance and processes between business, legal, procurement and compliance for airtight contracts. At what instances is a review of a standard contract needed?
• Importance of clear communication within your project team
• Procurements role in implementing training for budgeting and contracting within clinical trials